Outcomes
There were no significant between-group differences in maternal outcomes or neonatal outcomes . Serious adverse events were reported in 10 women in the induction group
(3%) and in 23 women in the expectant-management group (7%); most of these events were included in the prespecified secondary outcomes (Table S4 in the Supplementary Appendix). The groups did not differ materially with respect to the methods of induction (Table S5 in the Supplementary Appendix). A subgroup analysis of the primary outcome according to maternal age showed no significant difference in the treatment effects according to age